Fri, Aug 22, 2014, 6:05 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • fizrwinnr11 fizrwinnr11 Dec 15, 2012 9:37 PM Flag

    How the big pharmas are performing

    01) Up 28.6%. SNY (#06 in 2011, #10 in 2010)

    02) Up 16.4%. PFE (#02 in 2011, #06 in 2010)
    03) Up 16.2%. ABT (#04 in 2011, #09 in 2010)
    04) Up 15.5%. MRK (#08 in 2011, #03 in 2010)
    05) Up 15.0%. LLY (#03 in 2011, #05 in 2010)

    06) Up 10.5%. NVS (#10 in 2011, #01 in 2010)
    07) Up 07.8%. JNJ (#07 in 2011, #07 in 2010)

    08) Up 02.5%. AZN (#09 in 2011, #04 in 2010)
    09) Dn 03.3%. GSK (#05 in 2011, #08 in 2010)
    10) Dn 07.1%. BMY (#01 in 2011, #02 in 2010)

    Up 10.2%. Avg. of the ten big pharmas
    Up 09.5%. Avg. of PFE's nine big peers
    Up 10.6%. Avg. of the six domestic pharmas
    Up 09.5%. Avg. of PFE's five domestic peers
    Up 09.6%. Avg. of the four European pharmas

    Up 12.4%. S & P 500 (1,258 to 1,414)
    Up 07.5%. Dow 30 (12,218 to 13,135)

    Note: PFE is up from #05 two weeks ago and #04 last week. It is PFE's highest ranking of the year.

    Note: The difference between domestic pharmas and European pharmas has narrowed tremendously the last two month. On Oct. 19, there was a 7.8% positive difference between the domestics and the Europeans; now the difference is a mere 1%. For the first time in 2012, the Europeans are actually outperforming on balance PFE's five domestic peers.

    Sentiment: Buy

 
PFE
28.92+0.10(+0.35%)Aug 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.